August 12th 2025
Your daily dose of the clinical news you may have missed.
August 11th 2025
FDA accepts priority review of gepotidacin for uncomplicated urogenital gonorrhea, with phase 3 data showing non-inferiority to standard injectable therapy.
July 25th 2025
Nirsevimab lowered the risk of RSV-related illness by over 87% and hospitalizations by 98% in a new study.
July 24th 2025
Vaccination lowered influenza cases by about 33% to 42% in seasonal flu setups with 40% vaccine effectiveness, researchers reported.
July 17th 2025
Merck has launched phase 3 trials for MK-8527, a promising once-monthly HIV prevention pill, aiming to enhance PrEP options globally.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of May 24, 2022
Data from the CDC on boosters and US vaccination rates and from the Johns Hopkins COVID-19 interactive map on cases and deaths in the US and worldwide.
Three Doses of Pfizer’s COVID-19 Vaccine Well Tolerated in Children Under 5 Years of Age
Topline data showed that a third dose of the Pfizer-BioNTech vaccine was well tolerated among children with a safety profile similar to placebo.
FDA Grants EUA for At-home Triple Test: COVID-19, Influenza, RSV
The Labcorp home test, available without a prescription, is delivered overnight and includes a return envelope. Results are available in 1-2 days.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of May 23, 2022
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of May 20, 2022
CDC Greenlights COVID-19 Booster for Children Aged 5 to 11 Years
The CDC is encouraging parents of children in this age group to first finish a primary vaccination series, saying only 28% now are in that category.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of May 18, 2022
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of May 17, 2022
FDA Authorizes Pfizer-BioNTech COVID-19 Booster for Children Aged 5 to 11 Years
Children aged 5 to 11 years can receive a single dose booster shot 5 months after completing a primary 2-dose series of the Pfizer COVID-19 vaccine, FDA says.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of May 16, 2022
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of May 12, 2022
Shingrix: Who Needs It and Who Doesn't?
A 55-year-old healthy man has a rash on his back that is diagnosed as shingles. He has never received any shingles vaccine–is he eligible now? Plus 3 more patient scenarios.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of May 11, 2022
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of May 10, 2022
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of May 9, 2022
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of May 6, 2022
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of May 4, 2022
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of May 3, 2022
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of May 2, 2022
Study: Investigational RSV Vaccine Elicited Neutralizing Antibody Responses in Pregnant Women
Results from a phase 2b trial showed that a bivalent RSV prefusion F protein-based vaccine was safe and led to higher neutralizing antibody responses in pregnant women.
Remdesivir Wins FDA Approval for Treatment of COVID-19 in Youngest Patients
The US FDA expanded approval of remdesivir this week to include pediatric patients aged 28 days and older, the first COVID-19 treatment indicated for this population.
Moderna Announces Filing for Emergency Use Authorization for its COVID-19 Vaccine in Children Under Age 6 Years
The biotechnology company said on Thursday that similar requests are underway with international regulatory authorities.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of April 27, 2022
COVID-19 Epilogue: 10 Lessons Learned During 2 Long Years
Infectious disease expert and clinical investigator Rodger MacArthur, MD, considers what we know now that we didn't on March 12, 2020.
7 Questions on Latest US STD Trends
SAMPLE: Between 2019 and 2020, the rate of reported gonorrhea increased 10%. True or false? Plus, 6 more questions based on the CDC’s 2020 STD Surveillance Report.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of April 21, 2022
Preliminary Results Support Feasibility, Immunogenicity of Influenza-COVID-19 Combo Vaccine
Novavax reports that the various combinations assessed were safe and induced immune responses comparable to stand-alone formulations of both vaccines.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of April 20, 2022
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of April 19, 2022
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of April 18, 2022